Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Static Perimetry in Canthaxanthin Maculopathy

Static Perimetry in Canthaxanthin Maculopathy Abstract • We performed threshold static perimetry on 19 patients who had ingested canthaxanthin; 11 had maculopathy and eight did not. Patients with no history of canthaxanthin ingestion served as controls. All patients had visual acuity of 6/9 or better. Threshold static perimetry was reevaluated two to three years after cessation of canthaxanthin ingestion. For both testing sessions, patients with maculopathy presented lower retinal sensitivity than controls, while patients without maculopathy did not differ significantly from the control group. These results suggest that canthaxanthin retinopathy can adversely affect the neurosensory retina. References 1. Cortin P, Corriveau LA, Rousseau AP, et al: Maculopathie en paillettes d'or . Can J Ophthalmol 1982;7:103-106. 2. Segal A, Laporte P, Ducasse A, et al: Un nouveau cas de thésaurismose rétinienne à la canthaxanthine . Bull Soc Ophtalmol Fr 1985;85:145-147. 3. Saraux M, Laroche L: Maculopathie à paillettes d'or après absorption de canthaxanthine . Bull Soc Ophtalmol Fr 1983;83:1273-1975. 4. Metge P, Mandirac-Bonnefoy C, Bellaube P: Thésaurismose rétinienne à la canthaxanthine . Bull Mem Soc Fr Ophtalmol 1984;95:547-549. 5. McGuiness R, Beaumont P: Gold dust retinopathy after the ingestion of canthaxanthine to produce skin-bronzing . Med J Aus 1985;143: 622-623. 6. Ros AM, Leyon H, Wennersten G: Crystalline retinopathy in patients taking an oral drug containing canthaxanthine . Photodermatology 1985;2:183-185. 7. Meyer Von JJ, Bermond P, Pournaras C, et al: Canthaxanthin . Dtsch Apotheker Zeit 1985;21:1053-1057. 8. Weber U, Goerz G: Augenschaden durch Carotinoid-Einnahme . Dtsch Arzteblatt 1985;25:181-182. 9. Hennekes R, Weber U, Küchle HJ: Über canthaxanthinschäden der Netzhaut . Z Prakt Augeheilkd 1985;6:7-9. 10. Boudreault G, Cortin P, Corriveau LA, et al: La rétinopathie à la canthaxantine: I. Etude clinique de 51 consommateurs . Can J Ophthalmol 1983;18:325-328. 11. Cortin P, Boudreault G, Rousseau AP, et al: La rétinopathie à la canthaxanthine: II. Facteurs prédisposants . Can J Ophthalmol 1984;19:215-219. 12. Ray WA, O'Day DM: Statistical analysis of multi-eye data in ophthalmic research . Invest Ophthalmol Vis Sci 1985;26:1186-1188. 13. Brunette JR, Olivier P, Galeano C, et al: Hyper-response and delay in the electroretinogram in acute ischemia . Can J Ophthalmol 1983;18:188-193. 14. Daicker B, Schiedt K, Adnet JJ, et al: Canthaxanthin retinopathy . Graefes Arch Clin Exp Ophthalmol 1987;225:189-197.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Ophthalmology American Medical Association

Loading next page...
 
/lp/american-medical-association/static-perimetry-in-canthaxanthin-maculopathy-UhZb9hzVLf
Publisher
American Medical Association
Copyright
Copyright © 1988 American Medical Association. All Rights Reserved.
ISSN
0003-9950
eISSN
1538-3687
DOI
10.1001/archopht.1988.01060130064029
Publisher site
See Article on Publisher Site

Abstract

Abstract • We performed threshold static perimetry on 19 patients who had ingested canthaxanthin; 11 had maculopathy and eight did not. Patients with no history of canthaxanthin ingestion served as controls. All patients had visual acuity of 6/9 or better. Threshold static perimetry was reevaluated two to three years after cessation of canthaxanthin ingestion. For both testing sessions, patients with maculopathy presented lower retinal sensitivity than controls, while patients without maculopathy did not differ significantly from the control group. These results suggest that canthaxanthin retinopathy can adversely affect the neurosensory retina. References 1. Cortin P, Corriveau LA, Rousseau AP, et al: Maculopathie en paillettes d'or . Can J Ophthalmol 1982;7:103-106. 2. Segal A, Laporte P, Ducasse A, et al: Un nouveau cas de thésaurismose rétinienne à la canthaxanthine . Bull Soc Ophtalmol Fr 1985;85:145-147. 3. Saraux M, Laroche L: Maculopathie à paillettes d'or après absorption de canthaxanthine . Bull Soc Ophtalmol Fr 1983;83:1273-1975. 4. Metge P, Mandirac-Bonnefoy C, Bellaube P: Thésaurismose rétinienne à la canthaxanthine . Bull Mem Soc Fr Ophtalmol 1984;95:547-549. 5. McGuiness R, Beaumont P: Gold dust retinopathy after the ingestion of canthaxanthine to produce skin-bronzing . Med J Aus 1985;143: 622-623. 6. Ros AM, Leyon H, Wennersten G: Crystalline retinopathy in patients taking an oral drug containing canthaxanthine . Photodermatology 1985;2:183-185. 7. Meyer Von JJ, Bermond P, Pournaras C, et al: Canthaxanthin . Dtsch Apotheker Zeit 1985;21:1053-1057. 8. Weber U, Goerz G: Augenschaden durch Carotinoid-Einnahme . Dtsch Arzteblatt 1985;25:181-182. 9. Hennekes R, Weber U, Küchle HJ: Über canthaxanthinschäden der Netzhaut . Z Prakt Augeheilkd 1985;6:7-9. 10. Boudreault G, Cortin P, Corriveau LA, et al: La rétinopathie à la canthaxantine: I. Etude clinique de 51 consommateurs . Can J Ophthalmol 1983;18:325-328. 11. Cortin P, Boudreault G, Rousseau AP, et al: La rétinopathie à la canthaxanthine: II. Facteurs prédisposants . Can J Ophthalmol 1984;19:215-219. 12. Ray WA, O'Day DM: Statistical analysis of multi-eye data in ophthalmic research . Invest Ophthalmol Vis Sci 1985;26:1186-1188. 13. Brunette JR, Olivier P, Galeano C, et al: Hyper-response and delay in the electroretinogram in acute ischemia . Can J Ophthalmol 1983;18:188-193. 14. Daicker B, Schiedt K, Adnet JJ, et al: Canthaxanthin retinopathy . Graefes Arch Clin Exp Ophthalmol 1987;225:189-197.Crossref

Journal

Archives of OphthalmologyAmerican Medical Association

Published: Jan 1, 1988

References